Spotlight
Video

ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC

cancergrace has 777 videos Subscribe Here

Loading........
Description: http://cancerGRACE.org/...

Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.

GRACEcast 161 Lung
Shared By : cancergrace
Posted on : 08/14/13
Added : 4 years ago
Category : Other



Recommended

Nothing found.